Skip to main content
. 2020 Feb 13;106(3):303–314. doi: 10.1016/j.ajhg.2020.01.016

Table 1.

Summary of Biomarkers with Significant Proportion of Variation Explained by Local Ancestry in Using VC Analysis (p < 0.05/237)

Biomarker Both African Asian
Proportion Explained and p Value Proportion Explained(95% CI) p Value Proportion Explained(95% CI) p Value Proportion Explained(95% CI) p Value

C-peptide 0.24 (0.16, 0.32) 1.6 × 10−11 0.22 (0.15, 0.29) 9.9 × 10−12 0.02 (−0.02, 0.06) 0.13
eotaxin-3 0.22 (0.14, 0.29) 5.0 × 10−10 0.03 (0.00, 0.07) 0.02 0.19 (0.12, 0.25) 8.1 × 10−9
clusterin 0.18 (0.11, 0.25) 2.2 × 10−8 0.16 (0.10, 0.22) 1.6 × 10−8 0.02 (−0.01, 0.06) 0.10
fatty acid-binding protein liver 0.13 (0.07, 0.19) 2.4 × 10−6 0.11 (0.06, 0.16) 1.3 × 10−6 0.02 (−0.02, 0.06) 0.13
intercellular adhesion molecule-1 0.14 (0.08, 0.21) 3.1 × 10−6 0.08 (0.03, 0.13) 0.00018 0.06 (0.01, 0.11) 0.0042
apolipoprotein E 0.14 (0.07, 0.20) 4.0 × 10−6 0.10 (0.05, 0.15) 9.4 × 10−6 0.03 (−0.01, 0.08) 0.05
Fas ligand 0.14 (0.08, 0.20) 4.6 × 10−6 0.08 (0.03, 0.12) 0.00030 0.06 (0.02, 0.11) 0.0037
alpha-2 macroglobulin 0.12 (0.06, 0.18) 1.2 × 10−5 0.03 (0.00, 0.06) 0.038 0.09 (0.04, 0.14) 0.00010
apolipoprotein A-IV 0.12 (0.06, 0.18) 3.2 × 10−5 0.07 (0.03, 0.12) 0.00039 0.05 (0.00, 0.09) 0.017
interleukin-2 0.12 (0.06, 0.18) 4.0 × 10−5 0.11 (0.06, 0.16) 1.1 × 10−5 0.02 (−0.02, 0.06) 0.22
paraoxanase-1 0.11 (0.05, 0.17) 8.7 × 10−5 0.07 (0.03, 0.12) 0.00028 0.04 (−0.01, 0.08) 0.048

Biomarkers were residualized for age and sex.

CI = confidence interval